Company intelligence / Profile preview

Ellem Läkemedel

Danderyd, Sweden
Ownership
Private
Development stage
Other
01

Overview

Ellem Läkemedel was a Swedish pharmaceutical company focused on marketed over-the-counter consumer health products rather than a clinical development pipeline. The company was headquartered in Danderyd, Sweden, and was known for products including Bamyl, an analgesic tablet, and AfterBite, a topical product for insect bites. In 2008, Ellem was acquired by Meda, and the business subsequently became part of the Meda corporate structure. Because Meda itself was later acquired by Mylan in 2016, and Mylan subsequently became part of Viatris, Ellem is best understood as a legacy acquired Swedish pharma asset rather than an independent operating biotech company. The available public information does not indicate an active standalone R&D pipeline or platform technology under the Ellem name.

Therapeutic areas
NeurologyDermatology
Modalities
Small moleculeTopical formulation
Industry
Biotech

Beyond the preview

Go deeper on Ellem Läkemedel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ellem Läkemedel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call